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INTRODUCTION
Different types of trauma – bacterial or viral infec-
tions, as well as mechanical, thermal, and chemi-
cal injuries - lead to a disturbance in homeostasis. 
Consequently, in mammals a complex systemic reac-
tion that is referred to as the AP response becomes 
activated in order to reestablish homeostatic balance 
(K u s h n e r  and M a c k i e w i c z , 1987). During 
the AP response, pro-inflammatory cytokines and 
corticosteroids upregulate transcription factors that 
in turn induce the expression of AP protein genes 
in the liver (B a u m a n n  and G a u l d i e , 1994). A 
prominent AP protein in the rat is MG, whose serum 
concentration increases up to 100-fold during the 
AP response. MG is a glycoprotein that functions as 
a serum protease inhibitor and cytokine inactivator 
(G o n i a s , 1992). The generation of proteases is 
important in the development of different inflam-
matory conditions during the AP response, and 
their subsequent inhibition by MG plays an impor-
tant role in the resolution of the inflammatory state 
(S c h a e f e r  et al., 2004). Significant MG plasma 
levels are also normally observed during embryo-
genesis, in childhood, and in pregnancy – periods 
of life characterized by intense tissue growth and 
remodeling (G l i b e t i ć  et al., 1992, B o g o j e v i ć 
et al., 1998).
Previously, we described the participation of a 
transcription factor, tumor supressor protein p53, in 
transcriptional regulation of the AP proteins hapto-
globin and MG in the adult rat liver (B o g o j e v i ć 
et al., 2002; M i h a i l o v i ć  et al., 2005, 2007). While 
p53 seems to be dispensable for normal develop-
ment, it plays an important role in regulating cell 
proliferation in response to DNA lesions (L a c r o i x 
et al., 2006). Thus, p53 is viewed as a node for stress 
signals transduced mainly through the ability of p53 
to act as a transcription factor. The ability of p53 
to regulate transcription is linked to its affinity for 
a specific DNA sequence in the promoter element. 
The p53 consensus DNA-binding sequence is 5´-
puPuPuC(A/T)(A/T)GpyPyPy-3´ (E l - D e i r y  et 
al., 1992). Computer search of the extended MG 
promoter element (-852/+12) revealed the presence 
of two potential p53 binding sites at positions -289/-
298 and -131/-140 (Alggen Promo computer gene 
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analysis, available at www.alggen.Isi.upc.es/cgi/bin/
promo) (Fig. 1).
In the present work, we examined the poten-
tial role of p53 in transcriptional regulation of the 
MG gene in the fetal and adult liver under basal 
conditions and during the AP response. Since the 
activation of p53 occurs primarily as a result of post-
translational events rather than due to increased 
transcription of its gene (O r e n , 1999), in consider-
ing its involvement in MG gene regulation we cor-
related the affinity of p53 for the MG gene promoter 
with its post-translational (de)glycosylation.
MATERIALS AND METhODS
Animals
Male and female albino rats of the Wistar strain 
were used. Livers were isolated from 19-day-old 
fetuses removed from 10-week-old dams and 10-
week-old male adults. To obtain sufficient mate-
rial for one experiment, livers were pooled from 
up to five litters of 19-day-old fetuses (i.e., fetuses 
from up to five dams, depending on the number 
of fetuses in each litter), representing either the 
control or turpentine-treated groups. Livers from 
three adult (10-week-old) male rats were pooled for 
each group (control and turpentine-treated) per one 
experiment. From three to five separate experiments 
were performed for each group. The rats were kept 
at constant temperature, humidity, and dark/light 
intervals.
Induction of AP response
The AP response was induced by a subcutaneous 
injection of turpentine oil (1 μl/g of body weight) in 
the lumbar region of dams, neonatals, and male 
adults (B a u m a n n  et al., 1984). The animals were 
killed 12 h after turpentine injection.
Isolation of rat liver nuclear extract
Nuclear extracts were prepared from livers of 
control and turpentine-treated rats following the 
procedure described by G o r s k i  et al. (1986). 
Tissues were excised and homogenized in 10 mM 
hepes (ph 7.6), 25 mM KCl, 1 mM spermidine, 
1 mM dithiothreitol (DTT), 1 mM EDTA, 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 2 M sucrose, 
and 10% glycerol. Liver nuclei were collected by cen-
trifugation through a cushion of the same solution 
at 72,000 x g in a SW 28 rotor (Beckman L7-55) for 
30 min at 4°C. The nuclei were resuspended in lysis 
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buffer [10 mM hepes (ph 7.6), 100 mM KCl, 3 mM 
MgCl2, 0.1 mM EDTA, 1 mM DTT, 0.1 mM PMSF, 
and 10% glycerol]. The chromatin was pelleted by 
centrifugation of the lysate (82,000 x g, Ti 50 rotor, 
60 min, 4° C). Solid (Nh4)2 SO4 was added to the 
supernatant. The precipitated proteins were sedi-
mented at 82,000 x g in a Ti 50 rotor for 30 min at 
4°C. Nuclear extracts were dialyzed against 25 mM 
hepes (ph 7.6), 40 mM KCl, 0.1 mM EDTA, 1 mM 
DTT, and 10% glycerol, resuspended in dialysis buf-
fer, and kept at -80°C.
DNA affinity chromatography
In order to investigate whether p53 exhibits 
binding affinity for the MG gene promoter, soluble 
nuclear proteins and internal nuclear matrix pro-
teins were purified with a DNA affinity column 
and then examined by Western analysis. Affinity 
chromatography of sequence-specific DNA binding 
proteins from rat liver was performed by the method 
of K a d o n a g a  and T j i a n  (1986). A fragment of 
the MG gene (-825/+12) was annealed and ligated 
to obtain oligomers and then covalently coupled to 
Sepharose CL-2B with cyanogen bromide to yield 
the affinity resin. The DNA affinity resin was equili-
brated in a Bio-Rad Econo-Column with dialysis 
buffer [25 mM hepes (ph 7.6), 0.1 mM EDTA, 
1 mM DTT, and 10% glycerol] containing 0.1 M 
KCl. Equal quantities of fetal and adult liver nuclear 
extracts prepared from control and experimen-
tal animals were combined with competitor DNA 
(salmon sperm), allowed to stand for 30 min, and 
then passed through the DNA-Sepharose resin by 
gravity flow ("flow-through" fraction). The resin was 
washed with dialysis buffer containing 0.1 M KCl 
("rinse" fraction). The passage of buffer through the 
column was stopped, and dialysis buffer containing 
1 M KCl was added to the column. The resin was 
mixed with the buffer using a glass rod and allowed 
to stand for 10 min. After passage of buffer through 
the column, the eluate was collected. This step was 
repeated with dialysis buffer containing 1 M KCl.
Wheat-germ agglutinin affinity chromatography
Wheat-germ agglutinin (WGA) affinity chro-
matography was performed to examine the level of 
the N-acetylglucosamine (GlcNAc)-modified p53. 
Equal amounts of nuclear proteins prepared from 
fetal and adult liver in the basal state and 12 h after 
induction of the AP response were passed through 
the WGA column (jackson and Tjian, 1989). The 
glycosylated proteins were purified with 0.4 M 
N-acetylglucosamine and the presence of p53 was 
assessed by immunoblot analysis.
SDS-polyacrylamide gel electrophoresis and
Western immunoblot analysis
Protein concentrations were determined accord-
ing to the method of L o w r y  et al. (1951). For SDS-
polyacrylamide gel electrophoresis (SDS-PAGE), 
proteins (20 μg) were loaded onto 4% stacking/12% 
separating slab gels as described by L a e m m l i 
(1970). Nucleoproteins separated by SDS-PAGE 
were transferred to PvDF membranes (hybond-P, 
Amersham Pharmacia Biotech), and Western immu-
noblot analysis was performed by the procedure of 
To w b i n  et al. (1979) with polyclonal p53 antibody 
(FL-393, Santa Cruz Biotechnology, USA). After 
incubation with blocking solution [0.05% Tween 
20, 50 mM Tris-hCl (ph 7.6), 150 mM NaCl, and 
3% non-fat condensed milk], the membranes were 
incubated with specific antibodies for 2 h at room 
temperature. After rinsing, the blots were incubated 
with horseradish peroxidase-conjugated anti-rab-
bit immunoglobulin as a secondary antibody for 
1 h. Immunoreactive bands were identified by an 
enhanced chemiluminescence (ECL) detection sys-
tem (Santa Cruz Biotechnology) according to the 
manufacturer's instructions.
RESULTS AND DISCUSSION
Elevated MG gene transcription was shown to 
lead to a 100-fold increase in circulating MG during 
the AP response (O k u b o  et al., 1981). Expression 
of the MG gene is regulated at the transcriptional 
level, relying on the binding affinity of hepato-
cyte regulatory DNA-binding proteins for the pro-
moter region of the MG gene (D e  S i m o n e  and 
C o r t e s e , 1988). To assess the involvement of p53 
in MG gene expression, nuclear protein extracts 
were prepared from control and AP fetal and adult 
livers 12 h after turpentine administration, when 
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maximal transcriptional activity of the MG gene 
was observed (G l i b e t i ć  et al., 1992). Immunoblot 
analysis showed that p53 was present in the control 
nuclear extracts (Fig. 2, lanes 1 and 3) and that after 
induction of the AP response the relative amounts 
of p53 underwent a similar degree of increase in the 
nuclear extracts prepared from both fetal (lane 2) 
and adult (lane 4) rats.
Since there are two potentional p53-binding 
sites in the promoter region of the MG gene (Fig. 
1), the participation of p53 in transcriptional regu-
lation of the MG gene was examined by DNA-
affinity chromatography using the extended MG 
gene promoter (K a d o n a g a  and T j i a n , 1986). 
Immunoblot analysis of different protein fractions 
obtained after chromatography (Fig. 3) revealed 
that p53 in the fetal liver possessed binding affin-
ity for the MG promoter (lane 1). At 12 h of the AP 
response, p53 displayed increased promoter bind-
ing (lane 2). Although p53 did not bind to the MG 
promoter (lane 3) in the control adult liver, at 12 h 
of the AP response it exhibited promoter binding 
(lane 4). Thus, increased MG gene transcriptional 
activity was always accompanied by increased bind-
ing affinity of p53 for the MG promoter. This find-
ing suggests that p53 participated in transcriptional 
regulation of the MG gene.
In normal cells, p53 is latent. however, a variety 
of conditions and agents that cause genotoxic stress 
rapidly induce the expression of p53, which regu-
lates genes mediating cell cycle arrest and apoptosis. 
AP protein genes are induced during intense cellular 
stress characterized by macrophage activation and a 
cytokine-elicited oxidative burst (K o j , 1998). Both 
local and global inflammation frequently occur 
simultaneously with tissue hypoxia. Evidence for a 
direct link between low oxygen supply and induc-
tion of the AP response is provided by the obser-
vation that genes for interleukins (IL) 1 and 6, 
the mediators of the AP response, are induced in 
endothelial cells in vitro by hypoxia and that AP 
gene expression is stimulated following exposure of 
human hepatoma cells to moderate hypoxia (Ya n 
et al., 1995). A similar increased binding of p53 to 
an AP protein gene regulatory sequence during the 
AP response was observed at the hormone response 
element of the haptoglobin gene (B o g o j e v i ć  et 
al., 2002; M i h a i l o v i ć  et al., 2005). Since hypoxia 
is a physiological inducer of wild-type p53 (Wo n 
et al., 1998), the findings presented here suggest 
that hypoxia underlies the induction of p53 and its 
participation in the inducible expression of MG, 
haptoglobin, and probably other AP protein genes. 
Several viral and cellular promoters that do not con-
tain known p53-binding sites are repressed by p53, 
whereas promoters containing p53-binding sites are 
transactivated (G i n s b e r g  et al., 1991). The pres-
ence of predicted p53-binding sites on the MG pro-
moter, together with the observed increased binding 
affinity of p53 for the MG promoter during the AP 
response, lend additional support for a role of p53 in 
Fig. 2. Western immunoblot analysis of 
rat liver nuclear proteins with p53 anti-
body. Proteins (20 μg) were separated by 
12% SDS-PAGE, electrotransferred onto 
PVDF membranes and incubated with 
polyclonal rabbit antibody raised against 
rat p53. The antigen-antibody complex 
was visualized by the ECL detection 
system. Lanes 1 and 2 – 19 day-old fe-
tal liver; lanes 3 and 4 – 2.5-month-old 
adults. Lanes 1 and 3 – nuclear proteins 
isolated from control livers; lanes 2 and 
4 – nuclear proteins prepared 12 h after 
induction of the AP response.
Fig. 3. Western immunoblot analysis of 
nuclear proteins with p53 antibody after 
DNA-affinity chromatography.
Equal quantities of liver nuclear proteins 
were eluted from the DNA affinity col-
umn with 1 M KCl, and Western immu-
noblot analysis was performed with p53 
antibody. Lanes 1 and 2 – 19-day-old fe-
tal liver; lanes 3 and 4 – 2.5-month-old 
adult. Lanes 1 and 3 –nuclear proteins 
isolated from control livers; lanes 2 and 
4 – nuclear proteins obtained 12 h after 
induction of the AP response.
Fig. 4. Western immunoblot analysis of 
nuclear proteins with p53 antibody after 
WGA column.
Equal quantities of liver nuclear proteins 
were eluted from the WGA column with 
0.4 M N-acetylglucosamine, and Western 
immunoblot analysis was performed with 
p53 antibody. Lanes 1 and 2 – 19 day-fetal 
liver; 3 and 4–2.5-month-old adult. Lanes 
1 and 3 represent nuclear proteins isolated 
from the control livers; lanes 2 and 4 are 
nuclear proteins obtained 12 h after in-
duction of the AP response.
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the upregulation of MG expression.
Rapid post-translational activation of signaling 
proteins, including p53, is achieved through cova-
lent modifications such as phosphorylation, acetyla-
tion, and glycosylation (O r e n , 1999). The most fre-
quent type of intracellular glycosylation is through 
O-linkage of N-acetylglucosamine (GlcNAc). To 
examine the level of GlcNAc-modified p53, equal 
amounts of nuclear proteins prepared from fetal 
and adult livers during the basal state and 12 h after 
induction of the AP response were passed through 
a WGA column (j a c k s o n  and T j i a n , 1989). 
The glycosylated proteins were purified with 0.4 M 
N-acetylglucosamine, and the presence of p53 was 
assessed by immunoblot analysis (Fig. 4). As can 
be seen on lane 1, p53 in the control fetal liver was 
glycosylated, whereas the AP response was accom-
panied by its decreased glycosylation (lane 2). In 
the control adult liver, the level of p53 glycosylation 
was very high (lane 3), whereas the AP response was 
accompanied by a markedly decreased glycosylation 
of p53 (lane 4). Comparison of these findings with 
results obtained after DNA affinity chromatography 
and Western analysis revealed that increased bind-
ing affinity of p53 for the MG promoter during the 
AP response was accompanied by decreased glyco-
sylation of p53.
Phosphorylation reactions positively regu-
late p53 DNA binding (A s h c r o f t  et al., 1999). 
Previously, we showed that in vitro phosphoryla-
tion of control nuclei increased the binding affinity 
of p53 for the promoter region of the haptoglobin 
gene (B o g o j e v i ć  et al., 2002). Phosphorylation 
is tightly and dynamically regulated by protein 
glycosylation, and sugar and phosphate molecules 
compete for a single amino acid residue. hence, 
a decrease in the level of phosphorylation occurs 
after glycosylation and vice versa (h a l t i w a n g e r 
et al., 1997). Both O-glycosylation and phosphory-
lation affect the activation and stability of p53 
(A s h c r o f t  et al., 1999) and are sequentially impli-
cated in the modulation of p53 functioning and 
transactivation of p53-dependent/regulated genes. 
F i o r d a l i s o  et al. (1999) reported that hypergly-
cemia-induced enzymatic O-glycosylation of p53 
in myocytes decreases over time progressively and 
is replaced by its phosphorylation and increased 
DNA binding. The demonstration that inhibition of 
O-glycosylation prevented p53 phosphorylation and 
p53 activity suggests that these post-translational 
modifications are functionally linked. Based on our 
results, we conclude that the enzymatic removal of 
sugar moieties activated the binding potential of p53 
for the MG gene promoter.
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Транскрипциони факТор p53 показује повећан афиниТеТ везивања 
за промоТорски регион гена за а2-макроглобулин и смањен сТепен 
гликозијације у јеТри феТуса и аДулТа пацова Током
акуТно-фазног оДговора
Мирјана Михаиловић, Г. Познановић, Светлана Динић, невена ГрДовић, 
Мелита виДаковић, веСна Мартиновић и ДеСанка БоГојевић
Одељење за молекуларну биологију, Институт за биолошка истраживања "Синиша Станковић", 11060 Београд, Србија
Днк афинитетна хроматографија, са промотор-
ским регионом гена за ал­фа2-макрогл­обу­л­ин (МG) 
(-852/+12), и иму­нобл­от анал­иза су­ показал­е пове-
ћан афинитет везивања p53 за промоторски реги-
он гена за МG у­ контрол­ној јетри фету­са, као и у­л­о-
гу­ p53 у­ транскрипционој регу­л­ацији гена за МG и 
у­ фетал­ној и аду­л­тној јетри током аку­тно-фазног 
одговора (аФо). Повећање везивања p53 за про-
моторски регион гена за МG је праћено смањењем 
степена гл­икозил­ације p53. резу­л­тати су­геришу­ да 
у­ in vivo у­сл­овима у­кл­ањање шећерних остатака са 
p53 омогу­ћава његово везивање за промоторски 
регион МG гена, као и у­л­огу­ у­ транскрипционој 
активацији испитиваног гена током аФо.
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